Celonic is a CDMO/CMO based in Basel, Switzerland offering clients more than development and manufacturing services for New Biological Entities (NBEs) and Biosimilars worldwide. The services include the development of cell lines, production processes as well as the GMP and non-GMP manufacturing of biopharmaceutical drug substances. In addition Celonic licenses its proprietary SEFEX cell line technology to clients, drug developers and other service provider. In all aspects Celonic goes one step beyond expectations, to help its customers attain their goals better, more efficiently and reliably; thereby offering Biopharma-Business-Excellence. Celonic is driven by empathy, efficiency and excellence. The empathy helps to better understand the needs and value chains of the customers. Celonic offers efficiency through individually adapted interfaces from development to market production of biopharmaceutical substances enabled by the flexible and process driven structures. Excellence comes with wanting to excell. This is what Celonic wants to be measured by - in everything it does. Celonic cooperates with an international expert network and is part of a global operating company - the JRS Group.
You may also be interested in...
Unravelling the potential of nucleic-acid-based drugs